DPYSL2 and Alzheimer disease: Pharmacological preservation of CRMP2–ANT interaction via (S)-LCM confers mitochondrial and neuronal resilience in AD models, highlighting a potential therapeutic strategy for mitigating mitochondrial dysfunction and neurodegeneration.